Tom Bowman

Tom Bowman, MD MPH is an experienced medical leader currently serving as Medical Director at Beam Therapeutics since June 2024, focusing on clinical trials for Sickle Cell Disease. Previously, Tom contributed to various roles including Attending Hospitalist at Mass General Brigham, Senior International Medical Director at Novo Nordisk, and Senior Medical Director at Dicerna Pharmaceuticals. Tom's extensive background includes significant positions at Boston Scientific across multiple divisions, with a focus on clinical strategy and regulatory affairs. Academic appointments include Assistant Professor of Medicine at Harvard Medical School and clinician-researcher at Brigham and Women's Hospital, where Tom engaged in cardiovascular epidemiology research. Educational credentials include an MD from the University of Michigan Medical School and an MPH from Harvard T.H. Chan School of Public Health.